Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies

Heterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and immunogenicity of the poxvirus Modified Vaccinia Ankara (MVA) vectored vaccine expressing four Mycobacterium avium subspecies paratuberculosis antigens as...

Full description

Bibliographic Details
Main Authors: Folegatti, P, Flaxman, A, Jenkin, D, Makinson, R, Kingham, L, Bellamy, D, Ramos Lopez, F, Sheridan, J, Poulton, I, Aboagye, J, Tran, N, Mitton, C, Roberts, R, Lawrie, A, Hill, A, Ewer, KJ, Gilbert, S
Format: Journal article
Language:English
Published: MDPI 2021
_version_ 1826279010731032576
author Folegatti, P
Flaxman, A
Jenkin, D
Makinson, R
Kingham, L
Bellamy, D
Ramos Lopez, F
Sheridan, J
Poulton, I
Aboagye, J
Tran, N
Mitton, C
Roberts, R
Lawrie, A
Hill, A
Ewer, KJ
Gilbert, S
author_facet Folegatti, P
Flaxman, A
Jenkin, D
Makinson, R
Kingham, L
Bellamy, D
Ramos Lopez, F
Sheridan, J
Poulton, I
Aboagye, J
Tran, N
Mitton, C
Roberts, R
Lawrie, A
Hill, A
Ewer, KJ
Gilbert, S
author_sort Folegatti, P
collection OXFORD
description Heterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and immunogenicity of the poxvirus Modified Vaccinia Ankara (MVA) vectored vaccine expressing four Mycobacterium avium subspecies paratuberculosis antigens as a single dose or as a booster vaccine following a simian adenovirus (ChAdOx2) prime. We demonstrate that a heterologous prime-boost schedule is well tolerated and induced T-cell immune responses.
first_indexed 2024-03-06T23:52:27Z
format Journal article
id oxford-uuid:73129aad-62df-4dd9-b268-0d95f94c3211
institution University of Oxford
language English
last_indexed 2024-03-06T23:52:27Z
publishDate 2021
publisher MDPI
record_format dspace
spelling oxford-uuid:73129aad-62df-4dd9-b268-0d95f94c32112022-03-26T19:54:10ZSafety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspeciesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:73129aad-62df-4dd9-b268-0d95f94c3211EnglishSymplectic ElementsMDPI2021Folegatti, PFlaxman, AJenkin, DMakinson, RKingham, LBellamy, DRamos Lopez, FSheridan, JPoulton, IAboagye, JTran, NMitton, CRoberts, RLawrie, AHill, AEwer, KJGilbert, SHeterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and immunogenicity of the poxvirus Modified Vaccinia Ankara (MVA) vectored vaccine expressing four Mycobacterium avium subspecies paratuberculosis antigens as a single dose or as a booster vaccine following a simian adenovirus (ChAdOx2) prime. We demonstrate that a heterologous prime-boost schedule is well tolerated and induced T-cell immune responses.
spellingShingle Folegatti, P
Flaxman, A
Jenkin, D
Makinson, R
Kingham, L
Bellamy, D
Ramos Lopez, F
Sheridan, J
Poulton, I
Aboagye, J
Tran, N
Mitton, C
Roberts, R
Lawrie, A
Hill, A
Ewer, KJ
Gilbert, S
Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
title Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
title_full Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
title_fullStr Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
title_full_unstemmed Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
title_short Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
title_sort safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a mycobacterium avium complex subspecies
work_keys_str_mv AT folegattip safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT flaxmana safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT jenkind safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT makinsonr safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT kinghaml safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT bellamyd safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT ramoslopezf safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT sheridanj safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT poultoni safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT aboagyej safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT trann safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT mittonc safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT robertsr safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT lawriea safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT hilla safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT ewerkj safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies
AT gilberts safetyandimmunogenicityofadenovirusandpoxvirusvectoredvaccinesagainstamycobacteriumaviumcomplexsubspecies